NASD · Technology · Software - Infrastructure · Israel
Cellebrite DI Ltd is a mid cap company (market value between $2 billion and $10 billion) in the Software - Infrastructure industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Cellebrite DI Ltd stock.
Undervalued: intrinsic value $22.95 per share, market price $12.15, margin of safety 47.1% (as of 2026-10-30).
A 10.4x revenue multiple, adjusted for growth and margin, values the shares at $22.95; the price of $12.15 is 47% below that value.
Leak Score: 63/100 on 10 of 12 signals (Faint Leak).
5 more funds hold it; the full list is part of the paid plan.
All 181 Software - Infrastructure stocks
11 more in this industry show a wider margin of safety.
CLBT is undervalued (as of the 2026-10-30 close). A 10.4x revenue multiple, adjusted for growth and margin, values the shares at $22.95; the price of $12.15 is 47% below that value.
$22.95 per share (as of the 2026-10-30 close), against a market price of $12.15. That is a margin of safety of 47.1%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
63 out of 100, which we rate "Faint Leak", on 10 of 12 value investing signals.